GprA
GprA is a novel synthetic agonist for GPR120/FFAR4 with an AC50 of 203 nM on the full-length human receptor. It is a valuable research tool for investigating receptor function in metabolic disorders, including non-alcoholic fatty liver disease (NAFLD), in both in vitro and in vivo models.
Product Specifications
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
